Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Bradley Scroggins

Program Director, TRP

Division of Cancer Treatment and Diagnosis

Translational Research Program

240-276-7860

|

Bradley.Scroggins@nih.gov

Program Director

Translational Research Program

Portfolios: Bladder, Prostate, Kidney, Hyperactive RAS, Radiation and Radiosensitization

Bradley Scroggins, PhD, has served as a Program Director in the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) since 2023. Prior to joining, Dr. Scroggins worked in the NCI intramural Radiation Oncology Branch and the Urologic Oncology Branch. Dr. Scroggins has expertise in preclinical models of prostate, bladder, kidney cancer, radiation oncology and normal tissue damage, and protein homeostasis.